Related Experiment Video
Updated: Feb 8, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Association of Thromboembolic Risk Score with Left Atrial Thrombus and Spontaneous Echocardiographic Contrast in
Jun Huang1, Hong-Tao Liao2, Hong-Wen Fei2
1Department of Geriatrics, Guangdong General Hospital, Institute of Geriatrics, Guangdong Academy of Medical Sciences, Guangzhou, China.
Insights
Existing scores like CHADS2 and CHA2DS2-VASc are poor predictors of left atrial thrombus (LAT) and spontaneous echocardiographic contrast (SEC) in nonvalvular atrial fibrillation (NVAF) patients. A new scoring system using AF type and echocardiographic data shows improved prediction for these risks.
Area of Science:
- Cardiology
- Medical Diagnostics
- Thrombosis Research
Background:
- Nonvalvular atrial fibrillation (NVAF) patients are at risk for cardioembolic events.
- Left atrial thrombus (LAT) and spontaneous echocardiographic contrast (SEC) are indicators of this risk.
- Current scoring systems like CHADS2 and CHA2DS2-VASc have limitations in predicting these findings.
Purpose of the Study:
- To evaluate the association of CHADS2/CHA2DS2-VASc scores with LAT/SEC in non-anticoagulated NVAF patients.
- To develop and validate a novel scoring system for predicting LAT/SEC.
- To identify key predictors for LAT/SEC in this patient cohort.
Main Methods:
- A retrospective analysis of 2,173 consecutive non-anticoagulated NVAF patients.
- Transesophageal echocardiography was used to detect LAT/SEC.
- Multivariate analysis and receiver operating characteristic (ROC) curve analysis were employed.
Main Results:
- The prevalence of LAT/SEC was 4.9% in the study population.
- CHADS2 and CHA2DS2-VASc scores demonstrated low-to-moderate predictive value for LAT/SEC (ROC 0.591 and 0.608).
- Non-paroxysmal AF, reduced left ventricular ejection fraction, and left atrial enlargement were significant predictors, leading to a new scoring system with improved discrimination (ROC 0.792).
Conclusions:
- CHADS2/CHA2DS2-VASc scores have limited utility in predicting LAT/SEC in non-anticoagulated NVAF patients.
- A new scoring system incorporating AF type and echocardiographic parameters offers superior prediction of LAT/SEC.
- This novel system may serve as a better surrogate for cardioembolic risk assessment in NVAF.
Objectives:
The aim of the study was to examine the association of CHADS2/CHA2DS2-VASc scores with left atrial thrombus (LAT) and spontaneous echocardiographic contrast (SEC) in non-anticoagulated nonvalvular atrial fibrillation (NVAF) spontaneous patients, and to develop a new scoring system for LAT/SEC prediction.
Methods:
Consecutive non-anticoagulated NVAF patients with or without LAT/SEC by transesophageal echocardiography were identified in the Guangdong General Hospital.
Results:
Among 2,173 patients, the prevalence of LAT/SEC was 4.9%. Both predictive values of CHADS2 and CHA2DS2-VASc scores for the presence of LAT/SEC were low-to-moderate (receiver operating characteristic [ROC] = 0.591 and 0.608, respectively, p = 0.90). By multivariate analysis, non-paroxysmal AF, decreased left ventricular ejection fraction, and left atrial enlargement were positively associated with LAT/SEC, while CHADS2/CHA2DS2VASc scores were not. A new scoring system based on these 3 factors above significantly improved the discrimination for LAT/SEC (ROC = 0.792).
Conclusions:
CHADS2/CHA2DS2-VASc scores had limited value in predicting LAT/SEC; a new scoring system that combines AF type and echocardiographic parameters may better predict LAT/SEC as a surrogate for cardioembolic risk in NVAF patients.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Spontaneity
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Introduction to z Scores
z scores...

